| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |